Novel bivalent BET inhibitor N2817 exhibits potent anticancer activity and inhibits TAF1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel bivalent BET inhibitor N2817 exhibits potent anticancer activity and inhibits TAF1

Published:2021-03 Issue: Volume:185 Page:114435
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Wu Qian,Chen Dan-Qi,Sun Lin,Huan Xia-Juan,Bao Xu-Bin,Tian Chang-Qing,Hu Jianping,Lv Kai-Kai,Wang Ying-Qing,Xiong Bing,Miao Ze-Hong

Funder

Science and Technology Commission of Shanghai Municipality

National Major Science and Technology Projects of China

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference50 articles.

1. Disrupting acetyl-lysine interactions: recent advance in the development of BET inhibitors;Zhang;Curr. Drug Targets,2018

2. Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors;Romero;J. Med. Chem.,2016

3. Bromodomain biology and drug discovery;Zaware;Nat. Struct. Mol. Biol.,2019

4. BRDT is an essential epigenetic regulator for proper chromatin organization, silencing of sex chromosomes and crossover formation in male meiosis;Manterola;PLoS Genet.,2018

5. Interrogating histone acetylation and BRD4 as mitotic bookmarks of transcription;Behera;Cell Rep,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dipeptide PA3264 derived from rare and endangered Squama Manis is a novel bioactive peptide for the treatment of triple-negative breast cancer;Chinese Medicine;2024-08-21

2. The combination of methionine adenosyltransferase 2A inhibitor and methyltransferase like 3 inhibitor promotes apoptosis of non-small cell lung cancer cells and produces synergistic anti-tumor activity;Biochemical and Biophysical Research Communications;2024-07

3. Proteasome inhibitors reduce CD73 expression partly via decreasing p-ERK in NSCLC cells;Life Sciences;2023-11

4. Targeting bromodomain-containing proteins: research advances of drug discovery;Molecular Biomedicine;2023-05-05

5. Design and development of a novel series of oral bivalent BET inhibitors with potent anticancer activities;European Journal of Medicinal Chemistry;2022-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3